PALO ALTO, Calif., March 29, 2017 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) announced today that customers using Varian TrueBeam ® and Edge ™ radiosurgery solutions along with Eclipse ™ ...

Varian Medical Systems Inc. VAR recently announced that it will incorporate a multi-criteria optimization (MCO) radiotherapy treatment planning tool into its Eclipse treatment planning system. The ...

Palo Alto, CA-based Varian Medical Systems VAR recently announced that its Eclipse treatment planning software has been named 2017 Category Leader for Oncology Treatment Planning by KLAS. Notably, ...

Palo Alto, CA-based leading manufacturer of medical devices and software, Varian Medical Systems, Inc. VAR recently announced that its Eclipse treatment planning software has topped in two competitive ...

Varian Medical Systems, Inc. VAR recently announced that Paul Scherrer Institute ("PSI") Center for Proton Therapy has begun utilizing the company’s flagship Eclipse treatment planning system for ...

PALO ALTO, Calif., Sept. 18, 2017 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced the newest release of its treatment planning system, Eclipse 15.5. This new release has received ...

PALO ALTO, Calif., March 27, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced customers using Varian Eclipse ™ treatment planning software placed the highest in the overall category in the ...

Varian Medical Systems Inc.VAR is riding high on the back of its innovative product pipeline, regulatory wins and frequent product launches. The company recently launched ProBeam Compact System, which ...

PALO ALTO, Calif., May 28, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced a physicist using Varian's Eclipse ™ treatment planning system achieved the top overall score in the TROG 2019 ...

Varian Medical Systems (NYSE:VAR) recently announced the release of an FDA-approved treatment planning software — Eclipse 15.5. This will help clinicians treat with more accuracy and efficiency.